US 8598226
Fused cyclic compounds
granted A61PA61P1/04A61P1/14
Quick answer
US patent 8598226 (Fused cyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P1/04, A61P1/14, A61P13/12, A61P15/00